Camrelizumab in combination with neoadjuvant chemotherapy in resectable locally advanced esophageal squamous carcinoma cancer: Results from a retrospective study

Abstract This study aimed to evaluate the safety and efficacy of camrelizumab combined with chemotherapy during preoperative neoadjuvant therapy in patients with locally advanced resectable esophageal squamous cell carcinoma (ESCC) of clinical Stages II and III. The patients received camrelizumab pl...

Full description

Bibliographic Details
Main Authors: Ning‐Ning Kang, Hao Zheng, Jin‐Xiu Hu, Kai Cui, Pan‐Pan Si, Wei Ge
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:https://doi.org/10.1002/kjm2.12793